These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20479727)

  • 1. Mast cells in cutaneous inflammatory disorders.
    Soter NA
    J Invest Dermatol; 1983 Jun; 80(1 Suppl):22s-5s. PubMed ID: 20479727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells in cutaneous inflammatory disorders.
    Soter NA
    J Invest Dermatol; 1983 Jun; 80 Suppl():22s-25s. PubMed ID: 6854053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical urticaria/angioedema: an experimental model of mast cell activation in humans.
    Soter NA; Wasserman SI
    J Allergy Clin Immunol; 1980 Nov; 66(5):358-65. PubMed ID: 7002977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urticaria, angioedema, and mediator release in humans in response to physical environmental stimuli.
    Soter NA; Austen F
    Fed Proc; 1977 Apr; 36(5):1736-41. PubMed ID: 844616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous necrotizing venulitis: a sequential analysis of the morphological alterations occurring after mast cell degranulation in a patient with a unique syndrome.
    Soter NA; Mihm MC; Dvorak HF; Austen KF
    Clin Exp Immunol; 1978 Apr; 32(1):46-58. PubMed ID: 668192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural analysis of human skin biopsy specimens from patients receiving recombinant human stem cell factor: subcutaneous injection of rhSCF induces dermal mast cell degranulation and granulocyte recruitment at the injection site.
    Dvorak AM; Costa JJ; Monahan-Earley RA; Fox P; Galli SJ
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):793-806. PubMed ID: 9648707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.
    Kay AB
    Eur J Respir Dis Suppl; 1983; 129():1-44. PubMed ID: 6418559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of complement in urticaria and angioedema.
    Gelfand JA
    Clin Immunol Rev; 1981-1982; 1(2):257-309. PubMed ID: 6762276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentations and mechanisms of necrotizing angitis of the skin.
    Soter NA
    J Invest Dermatol; 1976 Sep; 67(3):354-9. PubMed ID: 787431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory properties of human C5a and C5a des Arg/ in mast cell-depleted human skin.
    Swerlick RA; Yancey KB; Lawley TJ
    J Invest Dermatol; 1989 Sep; 93(3):417-22. PubMed ID: 2527912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiinflammatory and immunosuppressive functions of mast cells.
    Kalesnikoff J; Galli SJ
    Methods Mol Biol; 2011; 677():207-20. PubMed ID: 20941613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders.
    Singh LK; Pang X; Alexacos N; Letourneau R; Theoharides TC
    Brain Behav Immun; 1999 Sep; 13(3):225-39. PubMed ID: 10469524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of phototoxicity in porphyria cutanea tarda and erythropoietic protoporphyria.
    Lim HW
    Immunol Ser; 1989; 46():671-85. PubMed ID: 2488874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell mediators with emphasis on intestinal mast cells.
    Metcalfe DD
    Ann Allergy; 1984 Dec; 53(6 Pt 2):563-75. PubMed ID: 6095703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Round Table: Urticaria and angioedema: introduction and classification].
    Alonso Lebrero E
    Allergol Immunopathol (Madr); 1999; 27(2):71-3. PubMed ID: 10354010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the mast cell in clinical gastrointestinal disease with special reference to systemic mastocytosis.
    Miner PB
    J Invest Dermatol; 1991 Mar; 96(3):40S-43S; discussion 43S-44S. PubMed ID: 2002261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent cutaneous necrotizing eosinophilic vasculitis. A novel eosinophil-mediated syndrome.
    Chen KR; Pittelkow MR; Su D; Gleich J; Newman W; Leiferman KM
    Arch Dermatol; 1994 Sep; 130(9):1159-66. PubMed ID: 7522002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.
    Chang TW; Chen C; Lin CJ; Metz M; Church MK; Maurer M
    J Allergy Clin Immunol; 2015 Feb; 135(2):337-42. PubMed ID: 24948369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines, fibrinolysis and vasculitis.
    Teofoli P; Lotti T
    Int Angiol; 1995 Jun; 14(2):125-9. PubMed ID: 8609438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.